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Background: This study aims to investigate anti-inflammatory effect of ethanolic extract of Myagropsis myagroides
(EMM) in the lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages and the phorbol 12-myristate 13-acetate
(PMA)-induced ear edema in mice, and to clarify its underlying molecular mechanisms.
Methods: The levels of nitric oxide (NO), prostaglandin E2 (PGE2), and pro-inflammatory cytokines were measured
by Griess assay and enzyme linked immunosorbent assay. The expressions of inducible nitric oxide synthase (iNOS),
cyclooxygenase-2 (COX-2), mitogen-activated protein kinases (MAPKs), and Akt were measured using Western
blotting. Nuclear translocation and transcriptional activation of nuclear factor-κB (NF-κB) were determined by
immunocytochemistry and reporter gene assay, respectively. PMA-induced mouse ear edema was used as the
animal model of inflammation. Anti-inflammatory compounds in EMM were isolated using high-performance liquid
chromatography and identified by nuclear magnetic resonance.
Results: EMM significantly inhibited the production of NO, PGE2, and pro-inflammatory cytokines in a
dose-dependent manner and suppressed the expression of iNOS and COX-2 in LPS-stimulated RAW 264.7 cells.
EMM strongly suppressed nuclear translocation of NF-κB by preventing degradation of inhibitor of κB-α as well as
by inhibiting phosphorylation of Akt and MAPKs. EMM reduced ear edema in PMA-induced mice. One of the
anti-inflammatory compounds in EMM was identified as 6,6’-bieckol.
Conclusions: These results suggest that the anti-inflammatory properties of EMM are associated with the
down-regulation of iNOS, COX-2, and pro-inflammatory cytokines through the inhibition of NF-κB pathway in
LPS-stimulated macrophages.
Keywords: Anti-inflammation, Myagropsis myagroides, MAPK, NF-κB, RAW 264.7 cellsBackground
Inflammation is a complex response of host defense
against microbial infection, endotoxin exposure, or cell
injury, and ultimately leads to the restoration of normal
cell structure and function. Macrophages are known to
play a key role in host defense mechanism, and are acti-
vated by exposure to interferon-γ, pro-inflammatory
cytokines, and bacterial lipopolysaccharides (LPSs) [1,2].* Correspondence: hrkim@pknu.ac.kr
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reproduction in any medium, provided the orActivated macrophages play a pivotal role in inflamma-
tory diseases by excessive production of pro-
inflammatory cytokines, including tumor necrosis factor
(TNF)-α, interleukin (IL)-1β, and IL-6, and inflammatory
mediators such as nitric oxide (NO) and prostaglandin
E2 (PGE2) [3,4]. Expressions of these cytokines and med-
iators are regulated by the activation of nuclear factor-
kappaB (NF-κB), which is critically involved in the
pathogenesis of rheumatism and other chronic inflam-
matory diseases [5]. In the unstimulated condition,
NF-κB is located in the cytoplasm as an inactive complex
bound to inhibitor of kappaB and (IκB)-α. Treatment of
LPS activates the IκB-α kinase (IKK) complex, resultingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of IκB-α, inducing the translocation of NF-κB into the
nucleus for transcriptional activation. The activation of
NF-κB is also regulated by cellular kinases such as
mitogen-activated protein kinases (MAPKs) and Akt
[6,7]. Hence, substances which inhibit the activation of
NF-κB are considered as potential anti-inflammatory
agents.
Myagropsis myagroides is one of the most abundant
brown algae, which has been used as a part of the diet
and folk medicines in Korea, Japan, and China for cen-
turies. This species contains high level of phlorotannins
and pigments. Recently, phlorotannins have been
reported to have several biological activities, such as
antioxidation [8], antidiabetic complications [9], antiam-
nesia [10], anti-inflammation [11], and hepatoprotection
[12]. As a biological activity of M. myagroides, previ-
ous study revealed a cytoprotective effect on carbon
tetrachloride-induced hepatotoxicity by its antioxidant
properties [13]. Recently, fucoxanthin isolated from
M. myagroides inhibited the production of inflammatory
mediators and pro-inflammatory cytokines via inhibiting
NF-κB activation in RAW 264.7 cells [14]. However, we
found an anti-inflammatory activity in the ethanolic ex-
tract of sun-dried M. myagroides (EMM) in LPS-
stimulated RAW 264.7 cells. Since fucoxanthin prone to
rapidly oxidized during sun-drying due to instability under
oxygen and sun light exposure, we hypothesized that other
anti-inflammatory compounds might be exist in EMM.
Furthermore, we confirmed that EMM does not contain
any detectable amount of fucoxanthin by HPLC chroma-
tographic analysis at 410 nm. To our knowledge, no previ-
ous study has been reported on the anti-inflammatory
activity of M. myagroides except fucoxanthin. Therefore,
we investigated the anti-inflammatory and anti-edema
properties of EMM and its underlying mechanisms
using cultured RAW 264.7 cells and identified anti-
inflammatory compound in EMM.
Methods
Chemicals
CellTiter96® AQueous One Solution Cell Proliferation
assay kit, luciferase assay kit, murine NF-κB promoter/
luciferase DNA, pRL-TK DNA and reverse transcript-
ase were obtained from Promega (Madison, WI,
USA). Primary antibodies and secondary antibodies
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Enhanced chemiluminescence (ECL)
detection kit was obtained from GE Healthcare Bio-
Science (Piscataway, NJ, USA). Dulbecco’s modified
Eagle's medium (DMEM), penicillin-streptomycin mix-
ture, 0.25% trypsin-ethylenediaminetetraacetic acid
(EDTA), and fetal bovine serum (FBS) were purchased
from Gibco BRL Life Technologies (Grand Island, NY,USA). 4’,6-Diamidino-2-phenylindole (DAPI), Alexa
FluorW 488-conjugated secondary antibody, Lipofecta-
mine/Plus, and TRIzol were purchased from Invitro-
gen (Carlsbad, CA, USA). LPS (Escherichia coli O55:
B5), bovine serum albumin (BSA), 2',7'-dichlorofluores-
cein diacetate (DCF-DA), dimethyl sulfoxide (DMSO),
indomethacin (Indo), and phorbol 12-myristate 13-
acetate (PMA) were purchased from Sigma-Aldrich
Corporation (St. Louis, MO, USA). Specific kinase inhibi-
tors (Wortmannin, PD98059, SP600125, and SB203580)
were purchased from Abcam (Cambridge, UK).
Preparation of EMM
M. myagroides was harvested from the coast of Busan,
South Korea, in April 2010. Taxonomic identification
was confirmed by an agal taxonomist (C.K Choi), at the
Department of Ecological Engineering, Pukyong
National University, Korea. The seaweed was rinsed in
tap water to remove salt, and air-dried under sunshine
for 3 days. A dried sample was ground with a hammer
mill and the powder was stored at −20°C until used. The
dried powder (500 g) of M. myagroides was extracted
three times with 96% ethanol (3 L/each) for 3 h at 70°C.
The combined extracts were filtered and concentrated
using rotary vacuum evaporator (Tokyo Eyela, Tokyo,
Japan) at 40°C and freeze-dried EMM (89.7 g) was
stored in freezer (−70°C) until used.
Cell culture and viability assay
Murine macrophage RAW 264.7 cells (ATCC, Rockville,
MD, USA) were cultured at 37°C in DMEM supplemen-
ted with 10% FBS, penicillin (100 units/mL), and
streptomycin sulfate (100 μg/mL). Cell viability was
determined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)
assay using a CellTiter96® AQueous One Solution Cell
Proliferation assay kit according to the manufacturer’s in-
struction. Briefly, cells were inoculated at a density of 5 ×
105 cells/well into 96-well plate and cultured at 37°C for
24 h. The culture medium was replaced with 200 μL of
serial dilutions of EMM, and the cells incubated for 24
h. The medium was replaced with 95 μL fresh medium
and 5 μL MTS solution. After 1 h, the absorbance at 490
nm was measured using a microplate reader (Glomax
Multi Detection System, Promega).
Measurement of NO, PGE2, TNF-α, IL-1α and IL-6
RAW 264.7 cells were plated in a 12-well plate at a
density of 1 × 106 cells/well and incubated for 24 h. Cul-
tured cells were treated with various concentrations of
EMM for 1 h, and then stimulated with 1 μg/mL LPS
for 24 h. Cultured media were collected after centrifuga-
tion at 2,000g for 10 min and stored at −70°C until
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was measured as an indicator of NO production, accord-
ing to the Griess reaction [15]. Levels of PGE2, IL-1β,
IL-6, and TNF-α in cultured media were quantitated by
enzyme-linked immunosorbent assay (ELISA, R&D Sys-
tems, Minneapolis, MN, USA) according to the manu-
facturer’s instructions.
Reverse transcription-polymerase chain reaction (RT-PCR)
RAW 264.7 cells placed in a 6-well plate were pretreated
with EMM for 1 h and then stimulated with LPS for 6 h.
Total RNA from each group was isolated with the TRI-
zol reagent. Five microgram of total RNA was used for
reverse transcription using oligo-dT-adaptor primer and
superscript reverse transcriptase. PCR was carried out
with the gene-specific primers: COX-2 sense, 5’-
CAGCAAATCCTTGCTGTTCC-3’; COX-2 antisense,
5’-TGGGCAAAGAATGCAAACAT-3’; iNOS sense, 5’-
CACCTTGGAGTTCACCCAGT-3’; iNOS antisense,
5’-ACCACTCGTACTTGGGATGC-3’; glyceraldehyde
3-phosphate dehydrogenase (GAPDH) sense, 5’-
GACCCCTTCATTGACCTCAA-3’; GAPDH antisense,
5’-CTTCTCCATGGTGGTGAAGA-3’. GAPDH was
used as an internal standard to evaluate relative ex-
pression of COX-2 and iNOS. Densitometric analysis
of the data obtained from at least three independent
experiments was performed using cooled CCD camera
system EZ-Capture II and CS analyzer ver. 3.00 soft-
ware (ATTO & Rise Co., Tokyo, Japan).
Transient transfection and luciferase assay
Murine NF-κB promoter/luciferase DNA (1 μg) along
with 20 ng control pRL-TK DNA was transiently trans-
fected into 2 × 105 RAW 264.7 cells/well in a 24-well
plate using Lipofectamine/Plus reagents for 40 h. Cells
pretreated with 0–100 μg/mL EMM for 1 h were stimu-
lated with LPS (1 μg/mL) for 6 h. Each well was washed
twice with cold phosphate-buffered saline (PBS), har-
vested in 100 μL of lysis buffer (0.5 mM HEPES, pH 7.8,
1% Triton N-101, 1 mM CaCl2, and 1 mM MgCl2) and
used for the measurement of luciferase activity using a
luciferase assay kit. Luminescence was measured on a
TopCount microplate scintillation and luminescence
counter (PerkinElmer, Santa Clara, CA, USA) in single-
photon counting mode for 0.1 min/well, following a 5
min adaptation in the dark. Luciferase activity was nor-
malized to the expression of control pRL-TK.
Preparation of cytosolic and nuclear extracts
RAW 264.7 cells (5 × 106 cells/well ) pretreated with
EMM for 1 h were stimulated with LPS for 0.5 h. Cells
were washed twice with cold PBS and harvested. Cell
pellets were resuspended in 300 μL of hypotonic buffer
[10 mM HEPES/KOH, 10 mM KCl, 2 mM MgCl2, 0.1mM EDTA, 1 mM DTT, and 0.5 mM phenylmethylsul-
fonyl fluoride (PMSF), pH 7.9] and incubated on ice for
15 min. After vortexing for 10 s, homogenates were
separated into supernatants (cytoplasmic compartments)
and pellets (nuclear components) by centrifugation at
13,000g for 10 min. The pellet was gently resuspended
in 40 μL complete lysis buffer (50 mM HEPES/KOH, 50
mM KCl, 1 mM DTT, 300 mM NaCl, 1% IGEPAL CA-
630, 0.1 mM EDTA, 10% glycerol, and 0.5 mM PMSF,
pH 7.9) and centrifuged at 13,000g for 20 min at 4°C.
The supernatant was used as the nuclear extract.
Western immunoblot analysis
RAW 264.7 cells were incubated with various concentra-
tions of EMM for 1 h and stimulated with LPS (1 μg/mL)
for 30 min. RAW 264.7 cells were washed twice with cold
PBS and lysed with lysis buffer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 1% IGEPAL CA-630, 1% Tween 20, 0.1%
SDS, 1 mM Na3VO4, 10 μg/mL leupeptin, 50 mM NaF,
and 1 mM PMSF) on ice for 1 h. After centrifugation at
18,000g for 10 min, the protein concentrations in the
supernatants were determined, and aliquots of the protein
(40 μg) were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred onto a nitrocellulose membrane. The mem-
brane was blocked with 5% nonfat dry milk in Tris-
buffered saline with 0.1% Tween 20 (TBST) for 1 h, fol-
lowed by the incubation for 2 h with primary antibody in
TBST containing 5% nonfat dry milk. The blots were trea-
ted with horseradish peroxidase-conjugated secondary
antibody in TBST containing 5% nonfat dry milk for 1 h,
and immune complexes were detected using an ECL de-
tection kit. Densitometric analysis of the data obtained
from at least three independent experiments was per-
formed using cooled CCD camera system EZ-Capture II
and CS analyzer ver. 3.00 software.
Immunofluorescence analysis
RAW 264.7 cells were maintained on glass coverslips
(SPL Lifesciences Co., Gyeonggi-do, Korea) to analyze
nuclear localization of NF-κB in 24-well plates for 24 h.
Cells treated with EMM for 1 h were incubated with
LPS (1 μg/mL) for 30 min as described in Lee et al. [16].
Cells were fixed in 4.0% paraformaldehyde in PBS for 15
min at room temperature, and then permeabilized with
0.5% Triton X-100 in PBS for 10 min. Cells were washed
with PBS and blocked with 3% BSA/PBS for 30 min.
Thereafter, cells were incubated with an anti-NF-κB
polyclonal antibody diluted in 3% BSA/PBS for 2 h, and
incubated with Alexa FluorW 488-conjugated secondary
antibody diluted in 3% BSA/PBS for 1 h. Cells were
stained with 2 μg/mL DAPI and images were captured
using an LSM700 laser scanning confocal microscope
(Carl Zeiss, Oberkochen, Germany).
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Animal studies were conducted after the experimental
protocols and procedures were approved by the Animal
Ethics Committee of the Pukyong National University.
ICR mice (male, 25–30 g) were purchased from the
Samtako Bio Korea Co. (Gyeonggido, Korea) and permit-
ted free access to a standard chow diet and tap water.
All mice were acclimatized for 1 week prior to the
experiments and maintained at 22 ± 2°C with a relative
humidity of 50 ± 5% and 12 h light–dark cycle. Ear
edema was induced on the right ear of mouse with PMA
according to Garrido et al. [16]. Briefly, the control
group received normal saline, and the other three groups
include a PMA alone, PMA + Indo (a positive control),
and EMM administered groups (PMA + EMM). The left
ear (reference) received the vehicle (30 μL acetone).
PMA (6 μg/ear in 30 μL acetone) was applied to the
inner surface of the right ear of ICR mouse. EMM (90
μg per ear in 30 μL acetone) or Indo (1 mg/ear in 30 μL
acetone) was topically administered 1 h before PMA ap-
plication. Six hours after PMA application, mice were
killed by cervical dislocation and a 6 mm diameter disc
from each ear was removed with a metal punch and
weighed. Ear edema weight was calculated by subtract-
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Figure 1 Effect of EMM on LPS-induced NO and PGE2 production in R
for 1 h were stimulated with LPS (1 μg/mL) for 24 h. The treated culture m
PGE2 production (B). Cytotoxic effect of EMM was measured by MTS assay
ap < 0.05 indicates significant differences compared to the control group. b
treated group.(treatment). Inhibition percentage (IP) was expressed as
a reduction in weight compared to the PMA-treated
group.
Isolation of phlorotannins from EMM
Aliquots of EMM were separated by Shimadzu high-
performance liquid chromatography (HPLC) system with
Luna RP-18 [Luna C18(2), 5 μm, 250 × 10 mm, Phe-
nomenex, Torrence, CA, USA]. The separation of EMM
was conducted using the mobile phase of 0.1% formic
acid in water (solvent A) and 0.1% formic acid in aceto-
nitrile (solvent B). The elution profile consisted of a lin-
ear gradient from 20 to 100% solvent B for 110 min and
hold for 15 min and then re-equilibration of the column
with 20% solvent B for 15 min. The flow rate was 0.34
mL/min at 35°C oven temperature and detection was
performed at 270 nm. The purity was determined by
HPLC (purity: >99%) and the chemical structure of the
isolated compounds were identified as eckol [17] and
6,6’-bieckol [8,12] by comparing their 1H- and 13C-NMR
data.
Statistical analysis
Data were expressed as the means ± standard deviations
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AW 264.7 cells. Cells pretreated with different concentrations of EMM
edia were used to measure the amount of NO production (A) and
(C). Values are the means ± SDs of three independent experiments.
p < 0.05 indicates significant differences compared to the LPS-only
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analysis of variance. Differences were considered signifi-
cant at values of p < 0.05. All analyses were performed
using SPSS for Windows, version 10.07 (SPSS Inc.,
Chicago, IL, USA).
Results
Effect of EMM on LPS-induced NO and PGE2 production
NO production, measured as nitrite, was increased by
LPS treatment; however, EMM significantly reduced NO
levels in LPS-stimulated cells in a dose-dependent man-
ner (p < 0.05, Figure 1A). Increased PGE2 production by
LPS was also significantly suppressed by 100 μg/mL
EMM in RAW 264.7 cells (Figure 1B). To exclude the
possibility that the decreased NO and PGE2 levels were
due to cell death, cytotoxicity of EMM was determined
by MTS assay. The result demonstrated that EMM showed
no cytotoxicity in RAW 264.7 cells up to 100 μg/mL
(Figure 1C). Thus, the inhibitory effects of EMM on NO
and PGE2 production were not due to cytotoxicity.
Effect of EMM on LPS-induced iNOS and COX-2 proteins
and mRNA expression
As shown in Figure 2, EMM strongly inhibited iNOS
protein production in a dose-dependent manner; how-
ever, COX-2 protein production was only inhibited by
100 μg/mL EMM, which is similar pattern observed in
the PGE2 secretion (Figure 1B). In addition to iNOS pro-
tein, EMM also inhibited iNOS mRNA expression in a
dose-dependent manner. Like inhibition of COX-2 pro-
tein, COX-2 mRNA expression was partially inhibited by
100 μg/mL EMM. These results suggest that the EMM-Figure 2 Effect of EMM on LPS-induced iNOS and COX-2 protein and
indicated concentration of EMM for 1 h and stimulated with LPS (1 μg/mL
SDS-PAGE. The expression of iNOS, COX-2, and β-actin protein was detecte
pretreated with EMM for 1 h and stimulated with LPS for 6 h, and then tot
representative of three independent experiments. ap < 0.05 indicates signif
significant differences compared to the LPS-only treated group.mediated inhibition of NO and PGE2 production in
LPS-stimulated macrophages is associated with downre-
gulation of iNOS and COX-2 expression at transcrip-
tional level.
Effect of EMM on LPS-induced pro-inflammatory
cytokines
Increased levels of IL-1β (Figure 3A), IL-6 (Figure 3B),
and TNF-α (Figure 3C) in RAW 264.7 cells by LPS
stimulation were dramatically reduced in a dose-
dependent manner by exposure to EMM (p < 0.05). This
result indicates that EMM efficiently suppressed LPS-
induced IL-1β, IL-6, and TNF-α release, which supports
the hypothesis that EMM inhibits the initial phase of the
LPS-stimulated inflammatory response.
Effect of EMM on LPS-induced activation and
translocation of NF-κB
Confocal microscopy revealed that NF-κB/p65 was dis-
tributed mostly in the cytoplasm in unstimulated cells.
After stimulation with LPS, most cytoplasmic NF-κB/p65
were translocated into the nucleus, as shown by strong
NF-κB/p65 intensity in the nucleus (Figure 4A). The level
of p65 in the nucleus was markedly reduced by treatment
with EMM. Considering the inhibitory effects of EMM
on LPS-induced NF-κB translocation into nucleus, we
determined the effect of EMM on the promoter activity
of NF-κB in LPS-stimulated cells. Data suggested that
EMM treatment significantly inhibited LPS-induced
NF-κB promoter activity (Figure 4B, p < 0.05).
LPS treatment resulted in increased IKKβ phosphoryl-
ation and IκB-α degradation compared to non-treatedmRNA expression in RAW 264.7 cells. (A) Cells were pretreated with
) for 16 h. Forty microgram of proteins were subjected to 10%
d by Western blotting using corresponding antibodies. (B) Cells were
al RNA was prepared for RT-PCR. The results presented are
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Figure 3 Effects of EMM on pro-inflammatory cytokine productions in LPS-stimulated RAW 264.7 cells. Cells were treated with various
concentrations of EMM for 1 h, and then stimulated with LPS for 24 h. IL-1β (A), IL-6 (B), and TNF-α (C) in the cultured media were measured by
ELISA. Data are means ± SDs of three independent experiments. ap < 0.05 indicates significant differences compared to the control group.
bp < 0.05 indicates significant differences compared to the LPS-only treated group.
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Figure 4 Effect of EMM on activation and translocation of NF-κB in RAW 264.7 cells. (A) Cells were pretreated with and without EMM for
1 h followed by LPS stimulation for 30 min. NF-κB/p65 subunits were probed by anti-NF-κB polyclonal primary antibody and Alexa FluorW
488-conjugated secondary antibody. The nuclei were stained with DAPI and the images were captured by confocal microscopy. (B) Cells
transfected with NF-κB promoter-containing luciferase DNA were pretreated with various concentrations of EMM for 1 h followed by LPS
stimulation for 6 h. ap < 0.05 indicates significant differences compared to the control group. bp < 0.05 indicates significant differences compared
to the LPS-only treated group.
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Figure 5 Inhibitory effect of EMM on the degradation of IκB-α and the activation of NF-κB in LPS-stimulated RAW 264.7 cells. Cells
were incubated with various concentrations of EMM for 1 h, and then stimulated with LPS (1 μg/mL) for 30 min. Cytosolic and nuclear fractions
were prepared and analyzed by Western blotting using corresponding antibodies. The results presented are representative of three independent
experiments. ap < 0.05 indicates significant differences compared to the control group. bp < 0.05 indicates significant differences compared to the
LPS-only treated group.
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phorylation and IκB-α degradation, recovered the control
level of cytosolic IκB-α in a dose-dependent manner
(Figure 5). As a result of IκB-α degradation, the increased
NF-κB level in nucleus after LPS stimulation was reduced
by EMM treatment in a dose-dependent manner (Figure 5).
However, phosphorylation of c-Jun, a component of tran-
scription factor AP-1, was not reduced by EMM treatment.
These results indicate that the EMM-mediated inhibition
of iNOS, COX-2, and pro-inflammatory cytokines pro-
duction was mainly regulated by the transcription factor
NF-κB in LPS-stimulated macrophages.
Effect of EMM on LPS-induced phosphorylation of MAPKs
and Akt
As shown in Figure 6A, EMM inhibited phosphorylation of
JNK, p38 MAPK, ERK, and Akt induced by LPS in RAW
264.7 cells, suggesting the additional characteristics of
EMM to regulate NF-κB pathway via blocking the phos-
phorylation of MAPKs and Akt proteins in response to LPS
signal. To further confirm the association of these signaling
molecules with the EMM’s anti-inflammatory effect, IκB-α
phosphorylations in LPS-stimulated RAW 264.7 cells were
measured in the presence of PI3K/Akt pathway inhibitor
(Wortmannin), ERK inhibitor (PD98059), JNK inhibitor(SP600125), or p38 inhibitor (SB203580). As shown in
Figure 6B, IκB-α phosphorylation was remarkably sup-
pressed by p38 inhibitor, which is consistent with the
result of Figure 6A. Other inhibitors such as Wortmannin,
PD98059, and SP600125, moderately inhibited the phos-
phorylation of IκB-α. These data confirm additional
characteristics of EMM on the phosphorylation of
MAPKs and Akt proteins for NF-κB activation in re-
sponse to LPS.
Effect of EMM on PMA-induced ear edema in mouse
Ear edema was induced by the application of PMA to the
mouse ears. As shown in Figure 7, the application of PMA
for 6 h significantly increased the weight of ear edema. Indo,
a common clinical non-steroidal anti-inflammatory drug,
was used as positive control for the inhibitory effect on the
ear edema. As shown in Figure 7, pre-treatment of 1 mg/ear
of Indo could effectively reduce ear edema after 6 h PMA
stimulation (p < 0.05). Similarly, pre-administration of
EMM (90 μg/ear) markedly inhibited the PMA-induced
ear edema with 66.8% inhibition (p < 0.05).
Isolation of anti-inflammatory compounds from EMM
EMM was further separated by reverse-phase column
chromatography (Figure 8A) for the isolation of anti-
Figure 6 Effect of EMM on the phosphorylations of MAPKs and Akt in RAW 264.7 cells. (A) Cells pretreated with indicated concentrations
of EMM for 1 h were stimulated with LPS (1 μg/mL) for 30 min. (B) Cells pretreated with indicated concentrations of EMM or inhibitors for 1 h
were stimulated with LPS (1 μg/mL) for 30 min. Whole cell lysates (40 μg) were analyzed by Western blotting using corresponding antibodies.
The results presented are representative of three independent experiments. ap < 0.05 indicates significant differences compared to the control
group. bp < 0.05 indicates significant differences compared to the LPS-only treated group.
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isolated compounds were identified as eckol and 6,6’-
bieckol, which were isolated for the first time from M.Figure 7 Effect of EMM on ear edema induced by PMA in
mouse. EMM, 6,6’-bieckol or indomethacin (Indo) was administered
topically on inner surface of the right ears of mice 1 h before
application of PMA. Six hours after application of PMA, ear edema
and the inhibition percentage (IP) of the ear edema by the
treatment were calculated. ap < 0.05 indicates significant differences
compared to the non-treated group. bp < 0.05 indicates significant
differences compared to the PMA-only treated group.myagroides, from the comparison of their NMR spectra
with the published spectral data. We obtained 2.5 mg of
eckol and 5.6 mg of 6,6’-bieckol from 1 g of EMM. The
purified 6,6’-bieckol significantly inhibited LPS-induced
iNOS and COX-2 production in a dose-dependent manner
(p < 0.05, Figure 8B), however, eckol did not affect on the
production of inflammatory proteins. Furthermore, pre-
administration of 6,6'-bieckol (30 μg/ear) markedly inhib-
ited the PMA-induced ear edema with 64.1% inhibition
(Figure 7, p < 0.05). The result indicates that 6,6’-bieckol is
one of the anti-inflammatory compounds in EMM.
Discussion
The present study was undertaken to examine the anti-
inflammatory effect of EMM on LPS-stimulated murine
macrophage cells. To further understood the molecular
mechanisms of EMM, we investigated the effects of
EMM on the secretion of NO, PGE2, TNF-α, IL-1β,
and IL-6, the expression of iNOS and COX-2, and the ac-
tivation of NF-κB. Our results indicated that EMM effect-
ively inhibited the secretion of NO, PGE2, TNF-α, IL-1β,
and IL-6 through a blockade of the NF-κB and MAPK
pathways in LPS-stimulated macrophages. The inhibitory
effect of EMM on the expression of inflammatory media-
tors suggested one of the mechanisms responsible for its
anti-inflammatory action and its potential for use as a
therapeutic agent for treating inflammatory diseases.
Figure 8 Identification of eckol and 6,6’-bieckol in EMM. (A) HPLC chromatogram of EMM and the chemical structures of eckol and 6,6’-
bieckol (insert). (B) Cells pretreated with different concentrations of eckol or 6,6’-bieckol for 1 h were stimulated with LPS for 16 h. The expression
levels of iNOS and COX-2 in cells were analyzed by Western blotting using corresponding antibodies. Relative density ratios of each protein over
β-actin are shown below the blots. The results presented are representative of three independent experiments. ap < 0.05 indicates significant
differences compared to the control group. bp < 0.05 indicates significant differences compared to the LPS-only treated group.
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mediators and pro-inflammatory cytokines produced by
activated macrophages cause inflammatory process and
act synergistically with other inflammatory mediators
[2,4,18]. Compounds able to reduce NO or PGE2 produc-
tion may be attractive as anti-inflammatory agents and, for
this reason, the inhibitory effects of natural compounds
on NO or PGE2 productions have been rigorously studied
to develop therapeutic agent against inflammatory diseases
[17,19,20]. Also, excessive production of pro-inflammatory
cytokines plays a critical role in acute inflammatory
responses as well as chronic inflammatory diseases. Recent
studies have shown that in vivo or in vitro treatments of
natural compounds are effective in reducing inflammation
by the suppression of pro-inflammatory cytokines, which
may ameliorate inflammation-related diseases, including
atherosclerosis, cancer, and inflammatory arthritis [21,22].
Thus, the regulation of those molecules is important tothe inhibition of inflammatory response. Our results indi-
cate that the inhibition of NO and PGE2 production by
EMM in LPS-stimulated macrophage cells is associated
with downregulation of iNOS and COX-2 genes (Figure 2),
which seems the first addressing transcriptional inhibition
of iNOS and COX-2 by EMM.
NF-κB is a transcription factor actively involved in the
transcriptional induction of iNOS and COX-2 gene [1,3].
Like NO and PGE2 produced by iNOS and COX-2, respect-
ively, the release of pro-inflammatory cytokines is regulated
by NF-κB pathway and plays an important role in the in-
duction of the innate immune response of the acquired im-
mune response [23]. It has been well studied that the
inhibition of NF-κB activation by black tea extract is asso-
ciated with the phosphorylation, ubiquitination, and subse-
quent degradation of IκB via ubiquitin-proteosome pathway
[24]. Although biochemical actions of EMM on NF-κB reg-
ulations remain unknown, the present study showed that
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IκB-α and the NF-κB promoter-driven luciferase expression
induced by LPS in RAW 264.7 cells. Therefore, these
results demonstrate the ability of EMM to inhibit NF-κB
activation in response to LPS signal in RAW 264.7 cells.
Hence it is likely that reductions of iNOS, COX-2, and pro-
inflammatory cytokine expression in RAW 264.7 cells are
largely associated with activation/deactivation of NF-κB
pathway. This report is, to our best knowledge, the novel
findings to address the functions of EMM through NF-κB
pathway in response to LPS treatment.
NF-κB is also regulated by various signaling kinases in-
cluding MAPKs (ERK, JNK, and p38) and Akt, which are
groups of signaling molecules to play key roles in NF-κB
activation [2,3]. MAPKs have been suggested to be
involved in pro-inflammatory signaling cascades and in
the activation of NF-κB in LPS-stimulated immune cells
[2,11]. Therefore, anti-inflammatory mechanisms are
closely related with inhibition of MAPKs in activated
RAW 264.7 cells. In this study, we found that phosphoryl-
ation of MAPKs in response to LPS was inhibited by
EMM treatment (Figure 6A). Interesting finding of this
study is that the activation of Akt, a downstream regulator
of PI3K, was also inhibited by EMM in response to LPS
signal in RAW 264.7 cells. Precise mechanisms by which
EMM modulate this PI3K/Akt pathway in the LPS stimu-
lation remains unclear. Considering a recent study with a
phlorofucofuroeckol A, which indicated a link between
ROS and PI3K/Akt pathway in regulations of inflamma-
tory genes [7,11], it is speculated that the antioxidant ac-
tivity of EMM or unknown components in EMM may be
related to inhibition of Akt phosphorylation. Thus, it is
likely that inhibition of MAPKs and Akt phosphorylation
by EMM may contribute to the EMM-mediated inhibition
of NF-κB pathway in LPS-stimulated RAW 264.7 cells.
Topical application of PMA to mouse skin induces in-
flammatory response and this is a well-established in vivo
model for the evaluation of various anti-inflammatory
agents. PMA can activate a wide variety of cell types that
may contribute to acute inflammation, resulting in an in-
crease in epidermal tissue swelling and infiltration of in-
flammatory cells [25,26]. The results from our in vivo
experiments clearly showed that EMM (90 μg/ear) sup-
pressed 66.8% of PMA-induced skin swelling. Further-
more, 6,6’-bieckol (30 μg/ear) isolated firstly from M.
myagroides in this study inhibited 64.1% of PMA-induced
skin swelling, indicating that it might be a main anti-
inflammatory compound in EMM. Although the inhibi-
tory activity of EMM is about one third of 6,6’-bieckol,
EMM showed higher anti-edema activity than Indo com-
pared to its concentration. This result demonstrates that
EMM can be used as a topical anti-inflammatory agent.
Like other polyphenolic compounds, phlorotannins, a
class of compounds polymerized with phloroglucinol unitsfound in brown seaweeds, have strong antioxidant [18,27]
and anti-inflammatory [11,28] activities. The multifunc-
tional antioxidant activity of phlorotannins is highly asso-
ciated with phenol rings which act as electron traps to
scavenge peroxy, superoxide-anions, and hydroxyl radicals
[29]. Specific mechanisms of phlorotannins on the anti-
inflammatory actions are not clearly defined. Considering
cellular signaling of polyphenols, phlorotannins may not
merely exert their effects as free radical scavenger, but
may also modulate inflammatory cellular signaling pro-
teins, including NF-κB and AP-1 transcription factors
[30]. Recent studies demonstrated that phlorofucofur-
oeckol A and 6,6’-bieckol isolated from Ecklonia spp. alle-
viate inflammatory response to LPS by inhibiting NF-κB
pathway with its intrinsic antioxidant activity [11,28]. In
the present study, the isolated 6,6’-bieckol from EMM
remarkably inhibited the production of iNOS and
COX-2 proteins, indicating 6,6’-bieckol is one of the
principle anti-inflammatory compounds in EMM.
Conclusions
We demonstrated that EMM inhibited the secretion of
inflammatory mediators, such as NO and PGE2, and
pro-inflammatory cytokines, including TNF-α, IL-1β,
and IL-6, in LPS-stimulated RAW 264.7 macrophages.
Moreover, the inhibitory effect of EMM was associated
with inactivation of the NF-κB pathway via blocking the
phosphorylation of MAPKs and Akt. In addition, the
results of in vivo study showed that EMM can be applic-
able to a topical anti-inflammatory agent.
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